RFK Jr’s COVID Warning Finally PROVEN? [Liberals STUNNED]
America is running one of the largest drug experiments in modern history.
And most people don’t even realize they’re in it.
GLP-1 drugs like Ozempic and Wegovy were originally designed for diabetes. Then they became weight-loss sensations.
Now?
Doctors are prescribing them for everything: Alzheimer’s. Addiction. Arthritis. Long COVID. Even aging itself.
In fact, GLP-1 prescriptions for people without diabetes exploded 700% between 2019 and 2023.
That’s not medicine anymore. That’s mass experimentation that is increasingly affecting vulnerable populations like seniors.
And before you become the next lab rat, there are three questions you need to ask your doctor.
Here’s what’s happening behind the scenes.
A massive 2025 analysis tracked 3.68 million GLP-1 prescriptions across the U.S.
Researchers found the median off-label prescribing rate was 37.7%.
In some wealthy counties?
More than half of prescriptions (51.6%) were for conditions the drugs were never officially approved to treat.
That matters. Because “off-label” doesn’t mean “proven.”
It means doctors are improvising. And when you’re talking about drugs that alter appetite, digestion, blood sugar, metabolism, and even brain signaling…
Improvising can get dangerous.
And that should sound familiar. Because we’ve seen this before.
OxyContin was originally approved for severe pain, like cancer pain and major injury recovery.
But it didn’t stay there.
Soon it was being prescribed for back pain. Arthritis. Fibromyalgia. Routine joint pain. Even minor chronic aches.
Doctors were told it was safe. Low addiction risk. A breakthrough.
Until America learned the hard way that expanding a drug beyond its original purpose can have devastating consequences.
I’m not saying GLP-1 drugs are the next OxyContin.
But I am saying this:
When a drug gets pushed into every corner of medicine before the long-term data is in…
That’s when the danger starts.
Yes, GLP-1 drugs can produce dramatic weight loss.
But they also come with growing concerns:
- Severe nausea and vomiting
- Muscle loss (not just fat loss)
- Gallbladder disease
- Pancreatitis
- Intestinal blockages
- Thyroid concerns
And here’s what worries HSI most:
We still do not have long-term data on what happens when millions stay on these drugs for years…or decades.
Especially seniors. Because after 60, rapid weight loss can be a double-edged sword.
Lose too much muscle, and your risk of falls, frailty, and hospitalization climbs fast.
That’s not anti-aging. That’s accelerated decline.
And now some doctors want to use these drugs to prevent dementia? Treat addiction? Reduce inflammation?
Maybe some of those uses will prove valuable. But maybe they won’t.
That’s the point. We don’t know yet.
And when uncertainty is this high, caution matters.
So if your doctor suggests a GLP-1 for anything beyond diabetes or obesity, ask:
- Is this FDA-approved for my condition?
- What are the long-term risks for someone my age?
- Is there a safer non-drug option first?
Because when medicine moves this fast…
Sometimes the public becomes the clinical trial.
To thinking first,
Ray Thatcher
Research Director, Health Sciences Institute
Sources:
Belluz, J. (2026, April 15). The great Ozempic experiment. The New York Times. https://www.nytimes.com/interactive/2026/04/15/opinion/glp1-health-effects.html
